Hospitals

Atlantis Orthopedics Selects eClinicalWorks Cloud EHR and healow to Improve Practice Efficiency and Enhance Patient Care

The orthopedic practice to utilize eClinicalWorks fully integrated practice management solution and Sunoh.ai AI medical scribeWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest...

LiveData to Showcase Safe Surgery Checklist Innovation for Situational Awareness and Patient Safety at IHI Patient Safety Congress 2024

CAMBRIDGE, Mass.--(BUSINESS WIRE)--#ActiveTimeOut--LiveData, a surgical capacity optimization solution company, today announced that it will demonstrate LiveData OR-Dashboard™ with Active Time...

Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements With PathAI

Transaction is part of wide-ranging collaboration to combine Quest's oncology expertise and scale with PathAI's AI and digital pathology innovations...

Real Time Medical Systems Empowers Clinicians to Drive Value-Based Care Outcomes with Post-Acute Partners at 2024 Spring Managed Care Forum

Industry’s leading post-acute analytics solution highlights ways ACOs, hospitals, health systems, and payers are leveraging live data to manage their...

New Study Published in JACC: Heart Failure Reveals that Despite Significant Efforts to Improve Acute Heart Failure Treatment Over the Past 20 Years, Management Remains Unchanged

-- Reprieve Cardiovascular Partners with Leading Heart Failure Researchers and Truveta to Analyze Real-World Heart Failure Patient Data to Highlight...

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows

KR-HT5 is based on Akoya’s PhenoImager® HT PlatformMARLBOROUGH, Mass. and SHANGHAI, China, May 02, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences,...

60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; No Material Changes Required

Trial planning and execution to proceed as planned WASHINGTON, May 02, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP;...

error: Content is protected !!